EpiThany Names David Poston as COO
EpiThany reported the appointment of David Poston as Chief Operating Officer.
According to a media release, Poston brings over 30 years of experience in finance and operations in the life science, engineering and technology industries.
Poston joins EpiThany from the Allen Institute, where he served as Chief Financial Officer and previously as Chief Operating Officer. Poston joined the Allen Institute in 2011 and helped plan, lead and support teams executing over $500 million of Institute expansion initiatives including the Institute's 10-year plan for the Allen Institute for Brain Science unit, the Institute's multiple-year plans for the Allen Institute for Cell Science and The Paul G. Allen Frontiers Group, and the construction of the Institute's 270,000 square foot headquarters building.
"David's sterling credentials and deep industry experience across multiple strategic financial and operational functions will be invaluable to EpiThany as we focus on advancing our pioneering cancer vaccine technology further in the clinic and establishing key partnerships," said Bill Watt, Ph.D., Founder, President and Chief Executive Officer of EpiThany. "We are thrilled to have David join us as we work to become the first company to develop Th1-selective, multi-antigen vaccines for patients with solid tumors."
Prior to the Allen Institute, Poston served as Vice President, Chief Financial Officer, Secretary and Treasurer for AmpliPhi Biosciences Corp. (formerly Targeted Genetics Corp.). Poston has previously held a series of finance and leadership positions at Corixa Corp. (now GSK), Honeywell Marine Systems (now Raytheon), Todd Shipyards Corp. (now Vigor Industrial), and Olin/Rocket Research Company (now Aerojet Rocketdyne).
"EpiThany is at an exciting stage in its development as it works to advance the promising science developed at the Tumor Vaccine Group, and I am very pleased to join this high caliber team," said Poston.
((Comments on this story may be sent to email@example.com))
THE DAILY VIEW
Tea Forté Introduces ‘Matcha’ Collection
Convenience meets tradition in Tea Forté’s new Ceremonial Matcha Bowl Set and the Matcha Single Steeps.
The company said its spring harvested, shade grown, stone ground, organic matcha tea is best served in a centuries-old Japanese tea ceremony called chanoyu: a preparation technique known for its centering meditative qualities.
"The launch of Tea Forté's Matcha collection represents our continued commitment to wellness and cultivating all the potential mental and physical health benefits of tea," says Tea Forté CEO Michael Gebrael. "In addition to our high quality Pure Matcha, we've also blended four distinct flavored Matcha varieties. Prepackaged in pouches measured out for a single serving, our Single Steeps Matcha is ideal for the office, travel, or to keep with you for a boost anytime."
Tea Forté noted its handcrafted ceremonial tea bowl, handmade bamboo whisk and measuring ladle “encourages serene enjoyment of our premium Kosher, gluten-free and vegan matcha blends.” These include: Pure Matcha, Chocolate Matcha, Coconut Matcha, Ginger Matcha, and Chai Matcha.
According to a release, in addition to its distinctive taste, matcha is prized for its health benefits. Steeped green tea contains only the antioxidants that can be extracted in water, while with matcha, the whole leaf is consumed.
Available now in select stores and online at teaforte.com.
Expedia.com has released a year-end look at U.S. traveler behavior and trends for 2017, analyzing data to identify the most in-demand destinations, hotels, activities and more.
Among other insights, the roundup revealed:
- Labor Day was the busiest weekend for car rental
- Disney Theme Parks topped the list of things to do
- The average hotel stay was two nights
- Top destinations based on 2017 air travel included major global cities like New York, London and Bangkok
- Popular tourist destinations included Orlando, Cancun and Las Vegas